Amin Zia

Amin Zia

Auto-generated profile, based on publicly available information

Amin Zia

Division of Immunology and Rheumatology, Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
Licun WuLicun Wu
Licun Wu
MKMikihiro Kohno
Mikihiro Kohno
JMJunichi Murakami
Junichi Murakami
AZAmin Zia
Amin Zia
JAJonathan Allen
Jonathan Allen
MPMarc de Perrot
Marc de Perrot
Defining the ontogeny of tumor-associated macrophages (TAM) is important to develop therapeutic targets for mesothelioma. We identified two distinct macrophage populations in mouse peritoneal and pleural cavities, the monocyte-derived, small peritoneal/pleural macrophages (SPM), and the tissue-resident large peritoneal/pleural macrophages (LPM). SPM rapidly increased in tumor microenvironment after tumor challenge and contributed to the vast majority of M2-like TAM. The selective depletion of M2-like TAM by conditional deletion of the Dicer1 gene in myeloid cells (D −/− ) promoted tumor rejection. Sorted SPM M2-like TAM initiated tumorigenesis in vivo and in vitro, confirming their capacity to support tumor development. The transcriptomic and single-cell RNA sequencing analysis demonstrated that both SPM and LPM contributed to the tumor microenvironment by promoting the IL-2-STAT5 signaling pathway, inflammation, and epithelial–mesenchymal transition. However, while SPM preferentially activated the KRAS and TNF-α/NFkB signaling pathways, LPM activated the IFN-γ response. The importance of LPM in the immune response was confirmed by depleting LPM with intrapleural clodronate liposomes, which abrogated the antitumoral memory immunity. SPM gene signature could be identified in pleural effusion and tumor from patients with untreated mesothelioma. Five genes, TREM2, STAB1, LAIR1, GPNMB , and MARCO , could potentially be specific therapeutic targets. Accordingly, Trem2 gene deletion led to reduced SPM M2-like TAM with compensatory increase in LPM and slower tumor growth. Overall, these experiments demonstrate that SPM M2-like TAM play a key role in mesothelioma development, while LPM more specifically contribute to the immune response. Therefore, selective targeting of monocyte-derived TAM may enhance antitumor immunity through compensatory expansion of tissue-resident TAM.

22 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
Eddie A. JamesEddie A. James
Eddie A. James
VHV. Michael Holers
V. Michael Holers
RIRadhika Iyer
Radhika Iyer
EPE. Barton Prideaux
E. Barton Prideaux
NRNavin L. Rao
Navin L. Rao
KDKevin D. Deane
Kevin D. Deane
Molecular markers of autoimmunity, such as antibodies to citrullinated protein antigens (ACPA), are detectable prior to inflammatory arthritis (IA) in rheumatoid arthritis (RA) and may define a state that is ‘at-risk’ for future RA. Here we present a cross-sectional comparative analysis among three groups that include ACPA positive individuals without IA (At-Risk), ACPA negative individuals and individuals with early, ACPA positive clinical RA (Early RA). Differential methylation analysis among the groups identifies non-specific dysregulation in peripheral B, memory and naïve T cells in At-Risk participants, with more specific immunological pathway abnormalities in Early RA. Tetramer studies show increased abundance of T cells recognizing citrullinated (cit) epitopes in At-Risk participants, including expansion of T cells reactive to citrullinated cartilage intermediate layer protein I (cit-CILP); these T cells have Th1, Th17, and T stem cell memory-like phenotypes. Antibody-antigen array analyses show that antibodies targeting cit-clusterin, cit-fibrinogen and cit-histone H4 are elevated in At-Risk and Early RA participants, with the highest levels of antibodies detected in those with Early RA. These findings indicate that an ACPA positive at-risk state is associated with multifaceted immune dysregulation that may represent a potential opportunity for targeted intervention.

3 May 2023 in The American Journal of Pathology
Verified
Journal Article
Closed access
AZAmin Zia
Amin Zia
YLYoav Litvin
Yoav Litvin
RVRonnie Voskoboynik
Ronnie Voskoboynik
AKAmit Klein
Amit Klein
CSCatherine Shachaf
Catherine Shachaf

15 November 2021 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YLYanling Liu
Yanling Liu
PBPatrick Budylowski
Patrick Budylowski
SDShilan Dong
Shilan Dong
ZLZhijie Li
Zhijie Li
SGSofiya Goroshko
Sofiya Goroshko
GEGoetz Ehrhardt
Goetz Ehrhardt
SARS-CoV-2 is a respiratory pathogen that can cause severe disease in at-risk populations but results in asymptomatic infections or a mild course of disease in the majority of cases. We report the identification of SARS-CoV-2–reactive B cells in human tonsillar tissue obtained from children who were negative for coronavirus disease 2019 prior to the pandemic and the generation of mAbs recognizing the SARS-CoV-2 Spike protein from these B cells. These Abs showed reduced binding to Spike proteins of SARS-CoV-2 variants and did not recognize Spike proteins of endemic coronaviruses, but subsets reacted with commensal microbiota and exhibited SARS-CoV-2–neutralizing potential. Our study demonstrates pre-existing SARS-CoV-2–reactive Abs in various B cell populations in the upper respiratory tract lymphoid tissue that may lead to the rapid engagement of the pathogen and contribute to prevent manifestations of symptomatic or severe disease. Key Points Pre-existing SARS-CoV-2–reactive B cells are found in tonsillar tissue. SARS-CoV-2–reactive Abs can be generated de novo. Pre-existing SARS-CoV-2–reactive Abs have neutralizing potential.

1 September 2007
Verified
Conference Paper
Closed access
AZAmin Zia
Amin Zia
JRJames P. Reilly
James P. Reilly
SSShahram Shirani
Shahram Shirani
In distributed coding of two correlated discrete sources, the objective is to reconstruct the sources' symbols at a common decoder. In contrast, in distributed estimation the main goal of coding is to protect the relevant information about the source parameters of interest. Thus it is useful to determine the rates under which the distributed estimator can achieve the same accuracy as it can in local estimation. In this paper we show that for fixed parameters, the rates in the Slepian-Wolf region is not only sufficient but also necessary for efficient estimation. The simple proof based on the method of types and large deviation theory leads to derivation of a lower-bound on the region of rates for a large class of bivariate sources.